Change - Announcement of Cessation::Resignation of Non-Executive Non-Independent Chairman

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
07-Feb-2022 19:06:51
Status
New
Announcement Sub Title
Resignation of Non-Executive Non-Independent Chairman
Announcement Reference
SG220207OTHRBGRM
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Resignation of Non-Executive Non-Independent Chairman

This announcement has been prepared by the Company and has been reviewed by United Overseas Bank Limited (the "Sponsor") for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lim Hoon Khiat, Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 65339898.

Additional Details

Name Of Person
Yee Pinh Jeremy
Age
52
Is effective date of cessation known?
Yes
If yes, please provide the date
07/02/2022
Detailed Reason (s) for cessation
Mr Yee Pinh Jeremy ("Mr Yee") has decided to resign as the Non-Executive Non-Independent Chairman of the Board of Directors ("Chairman") of Biolidics Limited (the "Company") to focus on his other existing work commitments.

Based on its enquiries, the Sponsor is satisfied that, save as disclosed in this announcement, there is no other material reason for the cessation of Mr Yee as Chairman of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
27/04/2017
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
4
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive Non-Independent Chairman, and a member of the remuneration committee of the Company ("RC")
Role and responsibilities
Responsibilities as Non-Executive Non-Independent Chairman, and a member of the RC
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
1,460,000 ordinary shares in the Company
Past (for the last 5 years)
1. Shanghai Kai Zhun Health Management Co. Ltd.
2. Clearbridge Medicentre Private Limited
3. Clearbridge Health (Philippines) Inc.
4. Halcyon Investment Capital Pte. Ltd.
5. Clearbridge Biophotonics Pte. Ltd.
6. Clearbridge Medical Asia Pte. Ltd.
7. Insight Medical Australia Pty Ltd
8. Biolidics Pty Ltd

Present
1. Clearbridge Assays Pte. Ltd.
2. Clearbridge BSA Pte. Ltd.
3. Clearbridge Lifestyle Pte. Ltd.
4. Clearbridge Medical Group Pte. Ltd.
5. SAM Laboratory Pte. Ltd.
6. Clearbridge Health Limited
7. Medic Laser Private Limited
8.Medic Surgical Private Limited
9. Clearbridge Health USA Inc.
10. Clearbridge Biophotonics FPM, Inc.
11. Clearbridge Medical Hong Kong Corporation Limited
12. QED Innovate Pte. Ltd. (In liquidation-members voluntary winding up)
13. Tri3 Capital Pte. Ltd.
14. Clearbridge Biomedics Pty Ltd